401816-50-0

Basic information

• Product Name: N-Cyclopropyl-4-[2-(4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine
• Synonyms: N-Cyclopropyl-4-[2-(4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine
• CAS NO: 401816-50-0
• Molecular Weight: 413.377
• Mol File: 401816-50-0.mol

Chemical Properties

• CAS DataBase Reference: N-Cyclopropyl-4-[2-(4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Cyclopropyl-4-[2-(4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine(401816-50-0)
• EPA Substance Registry System: N-Cyclopropyl-4-[2-(4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine(401816-50-0)

Safety Data

• Hazardous Substances Data: 401816-50-0(Hazardous Substances Data)

Upstream product

• 52334-81-3 2-chloro-5-trifluoromethylpyridine 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 145834-67-9 1-(4-fluorophenyl)-2-[5-(trifluoromethyl)-2-pyridyl]ethanone 
• 401816-45-3 3-(4-fluorophenyl)-2-(2-(5-trifluoromethyl)pyridyl)-2H-azirine 
• 372122-55-9 2-(4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-a]pyridine 
• 401816-47-5 2-(4-fluorophenyl)-3-(3-(dimethylamino)-2-propenoyl)-6-trifluoromethylpyrazolo[1,5-a]pyridine 
• 168627-33-6 N-cyclopropylguanidine 
• 401816-46-4 2-(4-fluorophenyl)-3-acetyl-6-trifluoromethylpyrazolo[1,5-a]pyridine 
• 372122-66-2 1-(4-fluorophenyl)-2-(2-(5-trifluoromethyl)pyridyl)ethanone oxime 

Relevant articles and documents

Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors

(Chemical Equation Presented) A convergent synthesis of substituted pyrazolo[1,5-a]pyridines has been achieved either via a regioselective [3 + 2] cycloaddition of N-aminopyridines with alkynes or by thermal cyclization of disubstituted azirines. Subseque

Fused pyrazole derivatives bieng protein kinase inhibitors

Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, (R2, and R4 are various substituent groups, are protein kinase inhibitors.